Home › Post-COVID Conditions (Long COVID) › Colorado › Aurora
Post-COVID Conditions (Long COVID) clinical trials in Aurora, CO
3 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus, Aurora
- University of Colorado Anschutz Medical Campus, Aurora
- University of Colorado Clinical and Translational Research Center, Aurora
- and 1 more
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
RecruitingPhase 3
- University of Colorado I Anschutz Medical Campus, Aurora
Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity
RecruitingHealthy volunteers welcome
- University of Colorado Hospital, Aurora
About Post-COVID Conditions (Long COVID)
Anyone who had COVID-19 can have ongoing symptoms. Learn about post-COVID conditions (long COVID), including symptoms, diagnosis, treatments, and prevention.
More about Post-COVID Conditions (Long COVID) on MedlinePlus
Post-COVID Conditions (Long COVID) trials in other cities
- New York City, NY15 studies
- Houston, TX13 studies
- Boston, MA13 studies
- Baltimore, MD12 studies
- Chicago, IL11 studies
- Washington, DC10 studies
- San Francisco, CA8 studies
- Durham, NC8 studies
- Atlanta, GA8 studies
- San Diego, CA7 studies
- Los Angeles, CA6 studies
- Pittsburgh, PA6 studies
Other studies in Aurora
- Cancer (all types)35 studies
- Colorectal Cancer32 studies
- Non-Small Cell Lung Cancer31 studies
- Breast Cancer28 studies
- Ovarian Cancer25 studies
- Metastatic Cancer25 studies
- Type 1 Diabetes23 studies
- Obesity22 studies
- Prostate Cancer19 studies
- Lung Cancer19 studies
- Heart Failure18 studies
- Melanoma18 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.